STOCK TITAN

Evotec Se Stock Price, News & Analysis

EVOTF OTC Link

Company Description

Evotec SE (EVOTF) is a drug discovery alliance and development partnership company that focuses on advancing innovative product approaches through collaborations with leading pharmaceutical and biotech companies, academics, patient advocacy groups, and venture capitalists. The company offers drug discovery solutions such as fee-for-service work, integrated alliances, development partnerships, licensing of innovative drug candidates, and consulting arrangements. With a global presence and a team of scientific experts, Evotec specializes in neuroscience, pain, metabolic diseases, oncology, inflammation, and infectious diseases. By utilizing state-of-the-art technologies and therapeutic expertise, Evotec aims to develop differentiated therapeutics on its comprehensive infrastructure.

Stock Performance

$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$1.5B
Market Cap
177.6M
Shares outstanding

SEC Filings

No SEC filings available for Evotec Se.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Diluted EPS (TTM)
Operating Cash Flow
Net Profit Margin
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Evotec Se (EVOTF)?

The current stock price of Evotec Se (EVOTF) is $8.98 as of July 3, 2025.

What is the market cap of Evotec Se (EVOTF)?

The market cap of Evotec Se (EVOTF) is approximately 1.5B.

What is Evotec SE known for?

Evotec SE is known for its focus on drug discovery and development partnerships with various stakeholders including pharmaceutical companies, academics, patient advocacy groups, and venture capitalists.

In which therapeutic areas does Evotec specialize?

Evotec specializes in neuroscience, pain, metabolic diseases, oncology, inflammation, and infectious diseases.

How does Evotec provide drug discovery solutions?

Evotec provides drug discovery solutions in the form of fee-for-service work, integrated alliances, development partnerships, licensing of innovative drug candidates, and consulting arrangements.

What sets Evotec apart from other companies in the industry?

Evotec leverages its scientific expertise, state-of-the-art technologies, and therapeutic knowledge to develop best-in-class and first-in-class therapeutics on its comprehensive infrastructure.

Can you name some of Evotec SE's long-term partners?

Evotec SE has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, CHDI, Genentech, and Janssen Pharmaceutica.